Lancet

• Latest
• Best
• Search…

• Lancet · Dec 2022

  Comment Letter

  Revisiting RECORD4.

  no abstract available

  expand abstract… or not…

• Lancet · Dec 2022

  A second-generation antibody-drug conjugate to treat HER2-positive breast cancer.

  no abstract available

  read more… mark as read…

• Lancet · Dec 2022

  Randomized Controlled Trial

  Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial.

  There is a paucity of evidence for dose and pace of up-titration of guideline-directed medical therapies after admission to hospital for acute heart failure. ⋯ Roche Diagnostics.

  explore further… or not…

• Lancet · Dec 2022

  Comment

  Ending age discrimination and stigma to promote healthy ageing in China.

  no abstract available

  read more… or just mark as read…

• Lancet · Dec 2022

  Department of Error.

  no abstract available

  read more… or not…